Volume 16, Number 9—September 2010
CME ACTIVITY - Research
Illicit Drug Use and Risk for USA300 Methicillin-Resistant Staphylococcus aureus Infections with Bacteremia
Table 1
Characteristic |
No. (%) |
---|---|
S. aureus isolate characteristics | |
USA300 MRSA | 67 (22) |
All other S. aureus | 233 (78) |
Non-USA300 MRSA | 117 (39) |
MSSA |
116 (39) |
Patient characteristics | |
Age, y, mean ± SD | 68 ± 13 |
Sex | |
M | 295 (98) |
F | 5 (2) |
Race | |
Black | 95 (32) |
Other | 205 (68) |
Year of presentation† | |
Late | 169 (56) |
Early | 131 (44) |
Charlson score, mean ± SD | 4.7 ± 3.0 |
HIV infection | |
Yes | 16 (5) |
No | 284 (95) |
Illicit drug use | |
Yes | 22 (7) |
No | 278 (93) |
History of colonization or infection with MRSA | |
Yes | 80 (27) |
No | 220 (73) |
Hospitalized in year before infection | |
Yes | 195 (65) |
No | 105 (35) |
Surgery in year before infection | |
Yes | 109 (36) |
No | 191 (64) |
Residence in LTCF in year before infection | |
Yes | 34 (11) |
No | 266 (89) |
Renal failure in year before infection | |
Yes | 114 (38) |
No | 186 (62) |
*Values are no. (%) except as indicated. MRSA, methicillin-resistant S. aureus; MSSA, methicillin-susceptible S. aureus; LTCF, long-term care facility.
†Year of presentation stratified into 2 periods: early (January 1, 2004–March 31, 2006) and late (April 1, 2006–June 30, 2008).
Page created: August 28, 2011
Page updated: August 28, 2011
Page reviewed: August 28, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.